HEALTH CATALYST INC (HCAT) Stock Price & Overview

NASDAQ:HCAT • US42225T1079

Current stock price

0.9963 USD
-0.01 (-1.36%)
At close:
1.01 USD
+0.01 (+1.38%)
After Hours:

The current stock price of HCAT is 0.9963 USD. Today HCAT is down by -1.36%. In the past month the price decreased by -44.34%. In the past year, price decreased by -74.65%.

HCAT Key Statistics

52-Week Range0.9551 - 5.062
Current HCAT stock price positioned within its 52-week range.
1-Month Range0.9551 - 1.4794
Current HCAT stock price positioned within its 1-month range.
Market Cap
73.318M
P/E
5.24
Fwd P/E
2.73
EPS (TTM)
0.19
Dividend Yield
N/A

HCAT Stock Performance

Today
-1.36%
1 Week
-14.85%
1 Month
-44.34%
3 Months
-59.66%
Longer-term
6 Months -62.40%
1 Year -74.65%
2 Years -83.98%
3 Years -92.09%
5 Years -98.28%
10 Years N/A

HCAT Stock Chart

HEALTH CATALYST INC / HCAT Daily stock chart

HCAT Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to HCAT. When comparing the yearly performance of all stocks, HCAT is a bad performer in the overall market: 97.52% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

HCAT Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to HCAT. Both the profitability and financial health of HCAT have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

HCAT Earnings

On March 12, 2026 HCAT reported an EPS of 0.08 and a revenue of 74.68M. The company missed EPS expectations (-13.81% surprise) and missed revenue expectations (-1.04% surprise).

Next Earnings DateMay 5, 2026
Last Earnings DateMar 12, 2026
PeriodQ4 / 2025
EPS Reported$0.08
Revenue Reported74.679M
EPS Surprise -13.81%
Revenue Surprise -1.04%

HCAT Forecast & Estimates

15 analysts have analysed HCAT and the average price target is 2.14 USD. This implies a price increase of 114.36% is expected in the next year compared to the current price of 0.9963.

For the next year, analysts expect an EPS growth of 91.99% and a revenue growth -9.74% for HCAT


Analysts
Analysts73.33
Price Target2.14 (114.79%)
EPS Next Y91.99%
Revenue Next Year-9.74%

HCAT Groups

Sector & Classification

HCAT Financial Highlights

Over the last trailing twelve months HCAT reported a non-GAAP Earnings per Share(EPS) of 0.19. The EPS decreased by -32.14% compared to the year before.


Income Statements
Revenue(TTM)311.14M
Net Income(TTM)-177.97M
Industry RankSector Rank
PM (TTM) N/A
ROA -35.41%
ROE -72.41%
Debt/Equity 0.62
Chartmill High Growth Momentum
EPS Q2Q%100%
Sales Q2Q%-6.19%
EPS 1Y (TTM)-32.14%
Revenue 1Y (TTM)1.48%

HCAT Ownership

Ownership
Inst Owners76%
Shares73.59M
Float64.67M
Ins Owners5.31%
Short Float %11.39%
Short Ratio7.99

About HCAT

Company Profile

HCAT logo image Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. The company is headquartered in South Jordan, Utah. The company went IPO on 2019-07-25. The firm's solution comprises its cloud-based data platform, applications, and expertise. Its segments include Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and earns primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally a combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its clients to fully configure and utilize the benefits of its technology offerings. Its clients, which are primarily healthcare providers, use its Solution to manage their data, derive analytical insights to operate their organization, and produce measurable clinical, financial, and operational improvements.

Company Info

IPO: 2019-07-25

HEALTH CATALYST INC

10897 South River Front Parkway, #300

South Jordan UTAH 84121 US

CEO: Daniel Burton

Employees: 0

HCAT Company Website

HCAT Investor Relations

Phone: 18017086800

HEALTH CATALYST INC / HCAT FAQ

What does HCAT do?

Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. The company is headquartered in South Jordan, Utah. The company went IPO on 2019-07-25. The firm's solution comprises its cloud-based data platform, applications, and expertise. Its segments include Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and earns primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally a combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its clients to fully configure and utilize the benefits of its technology offerings. Its clients, which are primarily healthcare providers, use its Solution to manage their data, derive analytical insights to operate their organization, and produce measurable clinical, financial, and operational improvements.


What is the stock price of HEALTH CATALYST INC today?

The current stock price of HCAT is 0.9963 USD. The price decreased by -1.36% in the last trading session.


Does HCAT stock pay dividends?

HCAT does not pay a dividend.


How is the ChartMill rating for HEALTH CATALYST INC?

HCAT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What sector and industry does HEALTH CATALYST INC belong to?

HEALTH CATALYST INC (HCAT) operates in the Health Care sector and the Health Care Technology industry.


What is the market capitalization of HCAT stock?

HEALTH CATALYST INC (HCAT) has a market capitalization of 73.32M USD. This makes HCAT a Micro Cap stock.